Publications
5539 Results
- Journal / Conference
- Cancer 103(7):1375-1380
- Year
- 2005
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Estimated impact of the prostate cancer prevention trial on population mortality
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 56:39-45
- Year
- 2005
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0109
A phase II study of flavopirodol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109
- Journal / Conference
- Annals of Oncology 16:1076-1080
- Year
- 2005
- Research Committee(s)
- Lung
- Study Number(s)
- S9714
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
- Journal / Conference
- Journal of Clinical Oncology 23(1):88-95
- Year
- 2005
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9451
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group trial
- Journal / Conference
- Journal of the National Cancer Intitute 97(2):94-102
- Year
- 2005
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
Designing the selenium and vitamin E cancer prevention trial (SELECT)
- Journal / Conference
- Investigational New Drugs 23:485-487
- Year
- 2005
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9924
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer. A Southwest Oncology Group (SWOG 9924) study.
- Journal / Conference
- Cancer Biomarkers & Prevention 14(3):727-730
- Year
- 2005
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
Centralized blood processing for the Selenium and Vitamin E Cancer Prevention Trial: Effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones and lymphocyte viability
- Journal / Conference
- ASCO 2005 Gastrointestinal Cancers Symposium #49
- Year
- 2005
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0127
SWOG 0127: phase II trial of erlotinib in GEJ and gastric adenocarcinomas
- Journal / Conference
- Leukemia 19:1880-1886
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- S9706
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG Trial SWOG 9706
- Journal / Conference
- Journal of Urology 173(4):451 (#1665)
- Year
- 2005
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794